Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
All content for Trends from the Trenches is the property of Bio-IT World and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
Episode: 28 - Bio-IT World Expo: Trends from the Trenches with Ari Berman
Trends from the Trenches
51 minutes
1 year ago
Episode: 28 - Bio-IT World Expo: Trends from the Trenches with Ari Berman
In this special episode of the Trends from the Trenches podcast, listen in on the Trends from the Trenches session at this year’s Bio-IT World Conference & Expo. Ari Berman, PhD, CEO of BioTeam, delivers a candid talk about the technologies driving data-intensive science, from the most worthwhile to the most overhyped to the most relevant. Learn what’s happening now with computing, storage, data transfer, networks, cloud, data science, machine learning, and more. Trends ...
Trends from the Trenches
Rare diseases do not receive enough attention for the impact they have on patients and their families. This is what AlphaRose’s founder and CEO Casey McPherson learned after his daughter was diagnosed with a rare condition. In a conversation with host Ari Berman, McPherson shares how he switched from music to founding his own pharmaceutical company, what technologies AlphaRose is developing, and how his company is creating environments that allow innovation and iteration. He also shares his t...
